Work

Abstract 453: Discovery of potent, selective, and orally bioavailable small molecule inhibitors of YTHDC1 for the treatment of MYC-driven cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-453

Authors: Richard C. Centore, Mark Charles, Mansi Arora, Marius Rebmann, Jerome Cattin, Xuejing Yang, Emily Batchelor, Matthew Watson, Nagakumar Bharatham, Prathima Radhakrishanan, Alex Howarth, Seema Qamar, Laura Andraghetti, Martin Kulander, Tuomas Knowles, Michael G. Kharas, Shilpi Arora

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: RNA modifications and cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409690784

Cites:

Cited by:

Related to: 10